US Puts Price Tag On False COVID-19 Claims
First Amendment No License For Health Care Providers To Make False Claims
Executive Summary
Until coronavirus public health emergency ends, FTC is authorized to order civil penalties of $43,792 per violation found in COVID-19-related advertising. Health care providers, meanwhile, advertising to treat COVID-19 might be unfamiliar with
You may also be interested in...
Same Old Supplement Claim Violations Prompt US Regulators’ Action Under New COVID-19 Authority
FTC files complaint against Quickwork as first action under authority granted in the COVID-19 Consumer Protection Act. The enforcement came after the firm twice ingored warnings to discontinue claims its vitamin D and zinc supplements were equal to or more effective than current vaccines.
Safe Use Of Hydrogen-Peroxide Contact Lens Solution Magnified in US FDA Draft Guidance
Draft guidance pulls from Ophthalmic Devices Panel and Risk Communication Advisory Committee 2017 meeting to discuss more clearly communicating risks of the solutions to consumers while allowing products to remain available OTC.
FDA Urges Stronger Labeling For Hydrogen Peroxide-Based Contact Lens Solutions
New draft guidance from the US agency calls for manufacturers to add more information about potential risks to the labeling of some types of contact lens solution.